Share Price Information
ThromboGenics is listed on the Eurolist by Euronext Brussels under the symbol THR.
As of 31 December 2014, ThromboGenics has a total number of 36,094,349 outstanding shares and a total number of 691,000 outstanding warrants.
View Shareholders History of Capital
Paying Agent Services
KBC Bank is acting as paying agent. The paying agent will not charge shareholders with respect to payments of dividends, the exercise of subscription rights, and other events concerning Thrombogenics’ shares. Shareholders should inform themselves about the amounts that other financial intermediaries may charge in connection with paying agency services.